首页> 外文期刊>Journal of Pharmaceutical Health Care and Sciences >A sensitive method for analyzing fluconazole in extremely small volumes of neonatal serum
【24h】

A sensitive method for analyzing fluconazole in extremely small volumes of neonatal serum

机译:一种敏感方法,用于分析氟康唑极小的新生儿血清

获取原文
       

摘要

Background:The need for a large volume of serum sample significantly reduces the feasibility of neonatal pharmacokinetic studies in daily practice, which must often rely on scavenged or opportunistic sampling. This problem is most apparent in preterm newborns, where ethical and practical considerations prohibit the collection of large sample volumes. Most of the fluconazole analysis assays published thus far required a minimum serum sample of 50 to 100?μL for a single assay. The purpose of the present study was to develop and validate a sensitive method requiring a smaller sample volume (10?μL) to satisfy clinically relevant research requirements.Methods:Following simple protein precipitation and centrifugation, the filtrated supernatant was injected into a liquid chromatography system and separated with a C18 reverse-phase column. Fluconazole and the internal standard (IS, fluconazole-d4) were detected and quantified using tandem mass spectrometry. The method was validated with reference to the Food and Drug Administration's Guidance for Industry. Accuracy and precision were evaluated at six quality control concentration levels (ranging from 0.01 to 100?μg/mL).Results:Investigated calibration curves were linear in the 0.01-100?μg/mL range. Intra- and inter-day accuracy (-?7.7 to 7.4%) and precision (0.3 to 6.0%) were below 15%. The calculated limit of detection and the lower limit of quantification (LLOQ) was 0.0019?μg/mL and 0.0031?μg/mL, respectively. Fluconazole in the prepared samples was stable for at least 4 months at -?20?°C and?-?80?°C. This method was applied to analyze 234 serum samples from ten neonates who received fosfluconazole, a water-soluble phosphate prodrug of fluconazole which converts to fluconazole in the body, as part of a pharmacokinetic study using daily scavenged laboratory samples. The median (range) concentration up to 72?h after fosfluconazole administration was 2.9 (0.02 to 26.8?μg/mL) μg/mL, which was within the range of the calibration curve.Conclusion:Fluconazole was able to be detected in an extremely small volume (10?μL) of serum from neonates receiving fosfluconazole. The method presented here can be used to quantify fluconazole concentrations for pharmacokinetic studies of the neonatal population by using scavenged samples.? The Author(s) 2020.
机译:背景:大量血清样品的需求显着降低了日常实践中新生儿药代动力学研究的可行性,这必须依靠清除或机会主义的采样。在早产新生儿中,这个问题最明显,其中道德和实际考虑禁止收集大型样本量。因此,大多数氟康唑分析测定的测定需要最小血清样品为单个测定法为50至100·μL。本研究的目的是开发和验证需要较小的样品体积(10≤μL)以满足临床相关的研究要求的敏感方法。方法:在简单的蛋白质沉淀和离心,将过滤的上清液注入液相色谱系统中并用C18反向相位柱分开。使用串联质谱法检测和定量氟康唑和内标(是,氟康唑-D4)。该方法是参考食品和药物管理局的行业指导验证。在六种质量控制浓度水平(范围为0.01至100μg/ ml)中,评估精度和精度。结果:所研究的校准曲线在0.01-100Ωμg/ ml范围内是线性的。日内和日间精度( - ?7.7至7.4%)和精度(0.3至6.0%)低于15%。计算的检测极限和定量下限(LLOQ)分别为0.0019Ωμg/ ml和0.0031Ωμg/ ml。制备的样品中的氟康唑在-20℃和α-·80Ω·℃下稳定至少4个月。应用该方法以分析来自接受FOSFOLUCONAZOLE的十个新生儿的234个血清样品,是使用每日清除实验室样品的药代动力学研究的一部分药代动力学研究的水溶性磷酸盐前药。在FOSluconazole给药后的中值(范围)浓度高达72Ω·h为2.9(0.02至26.8Ω·μg/ ml)μg/ ml,其在校准曲线的范围内。结论:能够在极端的情况下检测氟康唑来自新生儿的小体积(10?μl)来自Neonates接受fosluconazole的新生儿。这里呈现的方法可用于通过使用清除样品来量化新生儿群体的药代动力学研究的氟康唑浓度。作者2020年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号